Antibiotic allergy labels in immunocompromised populations. Issue 5 (18th October 2022)

• Record Type: Journal Article
• Authors: Waldron, Jamie L.; Trubiano, Jason A.
• Other Names: Forrest Graeme guestEditor.; Husain Shahid guestEditor.
• Is Part Of: Transplant infectious disease. Volume 24:Issue 5(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-10-18
• Subjects: antibiotic allergy -- antibiotic allergy testing -- cancer -- immunocompromised hosts -- hematopoietic stem cell transplant -- oral challenge -- skin testing -- solid organ transplant; Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.13955
• Languages: English
• ISSNs: 1398-2273

Abstract

Abstract: Antibiotic allergy labels (AALs) are commonly reported, with well‐defined prevalence in the general population; several studies have now focused efforts on immunocompromised hosts. Understanding the prevalence of reported allergy labels and methods of antibiotic allergy evaluation and delabeling strategies has the potential to improve prescribing practices and clinical outcomes in this high‐antibiotic use group. In this review, we will discuss the current literature on the prevalence, impact, and evaluations of AALs in immunocompromised hosts with a focus on beta‐lactam (penicillin) allergy and sulfa‐antibiotic (antimicrobial sulfurs) allergy labels.